F

Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436

Watchlist Manager
Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436
Watchlist
Price: 33.32 CNY -1.62% Market Closed
Market Cap: 5.3B CNY
Have any thoughts about
Fujian Cosunter Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Fujian Cosunter Pharmaceutical Co Ltd

There are no price targets for Fujian Cosunter Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Fujian Cosunter Pharmaceutical Co Ltd Competitors:
Price Targets
2070
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
22% Upside
GSK
GlaxoSmithKline PLC
15% Upside
IMP
Imexpharm Corp
0% Downside
LAURUSLABS
Laurus Labs Ltd
12% Downside
016580
Whanin Pharm Co Ltd
85% Upside
AUROPHARMA
Aurobindo Pharma Ltd
32% Upside
NEU
Neuren Pharmaceuticals Ltd
109% Upside
039200
Oscotec Inc
48% Upside

Revenue
Forecast

Revenue Estimate
Fujian Cosunter Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Fujian Cosunter Pharmaceutical Co Ltd's revenue is 4%. The projected CAGR for the next 7 years is -4%.

4%
Past Growth
-4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Fujian Cosunter Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Fujian Cosunter Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Fujian Cosunter Pharmaceutical Co Ltd's stock price target?
Not Available

Fujian Cosunter Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Fujian Cosunter Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-4%

For the last 8 years the compound annual growth rate for Fujian Cosunter Pharmaceutical Co Ltd's revenue is 4%. The projected CAGR for the next 7 years is -4%.

Back to Top